Cara Therapeutics Inc (CARA)
0.90
+0.03
(+3.57%)
USD |
NASDAQ |
Mar 28, 16:00
0.90
0.00 (0.00%)
After-Hours: 20:00
Cara Therapeutics Gross Profit (Quarterly): 2.396M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.396M |
September 30, 2023 | 3.308M |
June 30, 2023 | 5.515M |
March 31, 2023 | 3.575M |
December 31, 2022 | 1.131M |
September 30, 2022 | 7.758M |
Date | Value |
---|---|
June 30, 2022 | 23.00M |
March 31, 2022 | 2.709M |
December 31, 2021 | 0.821M |
September 30, 2021 | 20.27M |
June 30, 2021 | 0.00 |
March 31, 2021 | 1.935M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2021
23.00M
Maximum
Jun 2022
6.035M
Average
3.008M
Median
Gross Profit (Quarterly) Benchmarks
Nektar Therapeutics | 16.60M |
Stereotaxis Inc | 2.738M |
Cerus Corp | 25.96M |
Avid Bioservices Inc | -4.665M |
Rigel Pharmaceuticals Inc | 32.00M |